136 related articles for article (PubMed ID: 32449742)
21. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
[TBL] [Abstract][Full Text] [Related]
22. Effect of the contents and form of rabies glycoprotein on the potency of rabies vaccination in cattle.
Piza AT; Pieri KM; Lusa GM; Caporale GM; Terreran MT; Machado LA; Zanetti CR
Mem Inst Oswaldo Cruz; 2002 Mar; 97(2):265-8. PubMed ID: 12016455
[TBL] [Abstract][Full Text] [Related]
23. In vitro potency tests: challenges encountered during method development.
Yomayuza CL; Thiel HJ; König M
Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
Gamoh K; Shimazaki Y; Senda M; Makie H; Itoh O; Muramatsu M; Hirayama N; Hatakeyama H
J Vet Med Sci; 2003 Jun; 65(6):685-8. PubMed ID: 12867727
[TBL] [Abstract][Full Text] [Related]
25. Achieving scientific and regulatory success in implementing non-animal approaches to human and veterinary rabies vaccine testing: A NICEATM and IABS workshop report.
Poston R; Hill R; Allen C; Casey W; Gatewood D; Levis R; Mallet L; Smith D; Srinivas G; Stirling C; Allen D
Biologicals; 2019 Jul; 60():8-14. PubMed ID: 31255474
[TBL] [Abstract][Full Text] [Related]
26. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
Turki I; Hammami A; Kharmachi H; Mousli M
Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
[TBL] [Abstract][Full Text] [Related]
27. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
[TBL] [Abstract][Full Text] [Related]
28. An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies.
Welch RJ; Anderson BL; Litwin CM
J Med Microbiol; 2009 Jun; 58(Pt 6):806-810. PubMed ID: 19429758
[TBL] [Abstract][Full Text] [Related]
29. Fusion Peptide Improves Stability and Bioactivity of Single Chain Antibody against Rabies Virus.
Xi H; Zhang K; Yin Y; Gu T; Sun Q; Shi L; Zhang R; Jiang C; Kong W; Wu Y
J Microbiol Biotechnol; 2017 Apr; 27(4):718-724. PubMed ID: 28068664
[TBL] [Abstract][Full Text] [Related]
30. Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies.
Ng WM; Fedosyuk S; English S; Augusto G; Berg A; Thorley L; Haselon AS; Segireddy RR; Bowden TA; Douglas AD
Cell Host Microbe; 2022 Sep; 30(9):1219-1230.e7. PubMed ID: 35985336
[TBL] [Abstract][Full Text] [Related]
31. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.
Papaneri AB; Wirblich C; Marissen WE; Schnell MJ
Vaccine; 2013 Dec; 31(49):5897-902. PubMed ID: 24120673
[TBL] [Abstract][Full Text] [Related]
32. Rabies Vaccine Characterization by Nanoparticle Tracking Analysis.
Navarro Sanchez ME; Soulet D; Bonnet E; Guinchard F; Marco S; Vetter E; Nougarede N
Sci Rep; 2020 May; 10(1):8149. PubMed ID: 32424186
[TBL] [Abstract][Full Text] [Related]
33. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
Zhang S; Liu Y; Zhang F; Hu R
Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
[TBL] [Abstract][Full Text] [Related]
34. Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
Um J; Chun BC; Lee YS; Hwang KJ; Yang DK; Park JS; Kim SY
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006084. PubMed ID: 29267277
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use.
Korimbocus J; Dehay N; Tordo N; Cano F; Morgeaux S
Vaccine; 2016 Jun; 34(28):3310-6. PubMed ID: 27151880
[TBL] [Abstract][Full Text] [Related]
36. Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay.
Lafon M; Perrin P; Versmisse P; Sureau P
J Biol Stand; 1985 Oct; 13(4):295-301. PubMed ID: 3902842
[TBL] [Abstract][Full Text] [Related]
37. Feline herpesvirus vectored-rabies vaccine in cats: A dual protection.
Chen T; Zhou X; Qi Y; Mi L; Sun X; Zhang S; Liu Y; Olson V; Qiu W; Wu X; Hu R
Vaccine; 2019 Apr; 37(16):2224-2231. PubMed ID: 30878247
[TBL] [Abstract][Full Text] [Related]
38. A thermostable messenger RNA based vaccine against rabies.
Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
[TBL] [Abstract][Full Text] [Related]
39. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
40. An ELISA suitable for the detection of rabies virus antibodies in serum samples from human vaccinated with either cell-culture vaccine or suckling-mouse-brain vaccine.
Piza AS; Santos JL; Chaves LB; Zanetti CR
Rev Inst Med Trop Sao Paulo; 1999; 41(1):39-43. PubMed ID: 10436669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
